Please assess the completion status of the following clinical trial:

Trial Title: Cytokines and the Risk of Infection in Liver Cirrhosis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with clinical, radiological and/or histological evidence of liver cirrhosis~* Age above 18 (inclusive) at the time of screening~* Able and willing to give written informed consent and to comply with the requirements of the study~Exclusion Criteria:~* Infection during the last 14 days before screening~* Gastrointestinal bleeding within the last 14 days before screening~* Antibiotic therapy at the time of screening (except prophylaxis of spontaneous bacterial peritonitis)~* Shock or cardiac failure requiring inotrope treatment at the time of screening~* Hepatic encephalopathy grade \>2~* Findings suggestive of organic nephropathy or a serum creatinine level of more than 2 mg/dl~* Human immunodeficiency virus infection at time of inclusion~* Use of immunomodulating agents within one month prior to screening (e.g. steroids)~* Any disease (e.g., advanced neoplasia) that could affect the short-term prognosis~* Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the subject

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Liver Cirrhosis (Type: None): Single cohort of patients with liver cirrhosis to be investigated in the study. Two-monthly measurements of serum cytokines.

Based on this trial design, predict the completion outcome and termination type (if applicable).